Research Reports

Healthcare

icon
Home » Reports » Orthopaedic Oncology Market
Market Research Report

Orthopaedic Oncology Market By Treatment (Surgery, Chemotherapy, Radiation Therapy and Targeted Therapy); By End User (Hospitals and Research Laboratories) - Global Historical Growth (2012-2016) & Future Outlook (2017-2024) Demand Analysis & Opportunity Evaluation

Published On : 11:50 PM, 19th April, 2018 REP-ID-579 Category: Healthcare

Orthopaedic Oncology Market Overview

Orthopaedic oncology refers to the diagnosis and treatment of primary benign and malignant tumors of the bones and soft tissues. Orthopaedic oncology tumors include Ewing sarcoma, osteosarcoma, and other malignancies which involve the musculoskeletal system. Orthopaedic oncology represents a very small share in othropaedic. Orthopaedic oncology treatment includes surgery, chemotherapy, radiation therapy and targeted therapy.

Market Size and Forecast

Global orthopaedic oncology market is expected to grow at a significant CAGR during the forecast period i.e. 2017-2024. Factors such as rising prevalence of cancer and strong growth in healthcare sector in developing nations are anticipated to foster the growth of the global orthopaedic oncology market during the forecast period. Moreover, new products and development of advanced treatment methods is expected to bolster the sales of the orthopaedic oncology products.

In the regional market, North America is anticipated to dominate the overall market of orthopaedic oncology during the forecast period. High prevalence of cancer and rapid ageing geriatric population is expected to benefit the growth of orthopaedic oncology market. Apart from this, increasing spending on healthcare and high awareness is anticipated to impel the growth of the orthopaedic oncology market over the forecast period. Europe orthopaedic oncology market is expected to witness substantial growth over the forecast period. Rising penetration of cancer and musculoskeletal related disorders signals promising growth for orthopaedic oncology market in the region. Further, precision oncology is gaining momentum in gaining momentum in European countries and is anticipated to benefit the growth of the orthopaedic oncology market in the years ahead.

Bone and Joint

Moreover, Asia Pacific ranks as the fastest growing region in orthopaedic oncology market. Growing healthcare infrastructure and rise in the spending on medical treatment is predicted to trigger the growth of the orthopaedic oncology market in the next few years. Countries such as China, Japan, South Korea and India are witnessing augmented demand for orthopaedic oncology products.

Based on treatment, orthopaedic oncology market is segmented into surgery, chemotherapy, radiation therapy and targeted therapy, out of which, surgery segment is expected to dominate the overall orthopaedic oncology market during the forecast period.

Market Segmentation

Our-in depth analysis of the global orthopaedic oncology market includes the following segments:

By Treatment

  • Surgery
    • Amputation
    • Limb Salvage Surgery
    • Reconstructive Surgery
  • Chemotherapy
  • Radiation Therapy
  • Targeted Therapy

By End User

  • Hospitals
  • Research Laboratories

 By Region

The global orthopaedic oncology market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Russia, Poland, Turkey, BENELUX & Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Australia, New Zealand, Malaysia & Rest of Asia) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (GCC, Israel, North Africa and South Africa) Market size, Y-O-Y growth & Opportunity Analysis

Orthopaedic Oncology Market

Growth Drivers and Challenges

Increasing prevalence of musculoskeletal oncology is the major factor which is expected to intensify the growth of the orthopaedic oncology market. Further, rapid growth in ageing population in various developed nations is anticipated to positively impact the demand for orthopaedic oncology treatment during the forecast period. Apart from this, high growth in the number of new cases diagnosed in the past few years is expected to trigger the growth rate of global orthopaedic oncology market. Increasing healthcare expenditure and rising per capita income of the population is anticipated to positively impact the growth of the global orthopaedic oncology market. 

Favorable government initiatives and policies to limit the number of deaths from musculoskeletal cancer are anticipated to foster the growth of the global orthopaedic oncology market during the forecast period. Furthermore, rising number of multispecialty and cancer hospitals across the globe are envisioned to bolster the growth of global orthopaedic oncology market.

The market stands to benefit from increasing number of research and development activities. Moreover, development of precision oncology is offering profitable opportunities for the growth of the global orthopaedic oncology market.  

However, costly and complicated treatment therapies are a major stumbling block for the growth of orthopaedic oncology market. Lack of awareness about bone and musculoskeletal malignancies among the population is anticipated to negatively impact the growth of the global orthopaedic oncology market. Moreover, strict approval regulations are also slowing down the growth of orthopaedic oncology market.

Key Players

  • Stryker Corporation
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Amgen Inc.
  • Creganna Medical Group
  • Accentus Inc.
  • Canon Medical Systems
  • Siemens Healthineers
  • MD Anderson Cancer Center
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Sanofi S.A.

Scope and Context

Overview of the Parent Market

Analyst View

Segmentation

The global orthopaedic oncology market is segmented as follows:

  • By Treatment Market Size & Y-O-Y Growth Analysis
  • By End User Market Size & Y-O-Y Growth Analysis
  • By Region Market Size & Y-O-Y Growth Analysis

Market Dynamics

Supply & Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current dynamic environment

key Answers

SELECT LICENSE TYPE

KEY BENEFITS

  • DIRECT ANALYST ASSISTANCE

    Direct access to analyst to help you understand the market in a better way to handle your critical question

  • CUSTOMIZE AS PER YOUR NEED

    Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved

  • DISCOUNT ON CUSTOMISATION

    Get 10% free customization

  • QUALITY ASSURED

    Great focus on accuracy and quality of the research

Connect With Us

Call us

(U.S.) - +1 646 586 9123
(Canada) - +1 437 889 3230
(U.K.) - +44 203 608 5919
(India) - + 91 120 660 5495
Email: info@researchnester.com

Ask The Analyst

Delivery Center

1014, 10th Floor, Tower A1,
Ansal Corporate Park, Plot no 7A/1,
Sector 142 Noida., 201301 India
info@researchnester.com

US Office

1820 Avenue M, Suite# 1113,
Brooklyn, New York 11230
Phone : +1 646 586 9123
info@researchnester.com

Canada (Toronto)

Phone : +1 437 889 3230
info@researchnester.com

UK Office (London)

Phone : +44 203 608 5919
info@researchnester.com

Copyright © 2018 Research Nester. All rights reserved

Top